AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05389046 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Escitalopram+Aripiprazole+omega-3 PUFAs
Description: Escitalopram+Aripiprazole+omega-3 PUFAs
Study NCT05726916 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Soliris®
Description: Eculizumab IV administration (900mg/w during 4w then 1200 mg at w5 and 1200mg/2w for 8w) + Blood pressure control with renin angiotensin system blockers
Study NCT05726916 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Renin angiotensin system blockers
Description: Blood pressure control with renin angiotensin system blockers
Study NCT04701788 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: 23-valent pneumococcal polysaccharide vaccine
Description: The study group and the control group were injected with a dose of 23-valent pneumococcal polysaccharide vaccine. One month later, blood was collected and serum was separated.
Study NCT04701788 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: 23-valent pneumococcal polysaccharide vaccine
Description: The study group and the control group were injected with a dose of 23-valent pneumococcal polysaccharide vaccine. One month later, blood was collected and serum was separated.
Study NCT05570916 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Zip-stitch(R)
Description: Zip-stitch clips for vaginal cuff closure during laparoscopic hysterectomy
Study NCT05570916 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Reference suture
Description: Standard suture for vaginal cuff closure during laparoscopic hysterectomy
Study NCT05647291 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: extracorporeal Shock wave therapy
Description: Two thousand pulses with a frequency of 6 Hz and a pressure of 3 bar were applied to patients with an Auto Wave 695 (Mettler electronics, USA) brand device. Patients underwent two sessions of ESWT per week, for two weeks, adding up to a total of 4 sessions.
Study NCT05647291 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Corticosteroid injection
Description: 40mg/1ml methylprednisolone, two sessions once a week
Study NCT05647291 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Kinesiotaping
Description: The first strip was adhered along the plantar fascia from the calcaneus to the toes using maximum stretch. The other four strips of tape were attached medially and laterally to support the medial longitudinal arch with a 45° inclination. While maximum stretching was applied to the middle 1/3 of all bands, no stretching was applied to the ends. Once a week, three times
Study NCT05594641 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Remote ischaemic preconditioning
Description: A tourniquet will be applied to the right arm and it will be inflated (3 cycles, each lasting 5 minutes, at a pressure of 200 mmHg); each cycle is followed by 5 minutes of resting
Study NCT05594641 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control
Description: The tourniquet will be applied to the right arm but the cuff will be not inflated
Study NCT05700617 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 1:1 Randomization to receive milrinone or dobutamine
Description: Randomized to receive either inotropic agent: milrinone or dobutamine
Study NCT05700617 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 1:1 Randomization to receive dobutamine or milrinone
Description: Randomized to receive either inotropic agent: milrinone or dobutamine
Study NCT06216262 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control group
Description: Brushing teeth twice a day for 8 weeks
Study NCT06216262 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Arginine
Description: Brushing teeth twice a day for 8 weeks
Study NCT06216262 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Novamin
Description: Brushing teeth twice a day for 8 weeks
Study NCT06216262 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Propolis
Description: Brushing teeth twice a day for 8 weeks
Study NCT06216262 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Casein Phosphopeptide Amorphous Calcium Phosphate
Description: Following the procedure in the control group, it is applied to the tooth surface once a day for 3 minutes before going to bed at night for 8 weeks
Study NCT06216262 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Potassium Nitrate
Description: Following the procedure in the control group, mouthwash twice a day in the morning and evening for 8 weeks
Study NCT05657171 — intervention group
Intervention type: DRUG
Intervention: cyproterone Acetate/Ethinyl Estradiol Combination
Description: cyproterone acetate (CPA) 2 mg, combined with EE 35 µg.
Study NCT05732870 — intervention group
Intervention type: PROCEDURE
Intervention: Relevant orthopaedic surgery
Description: Inclusion criteria is purposefully broad to examine a range of discarded bone waste. Therefore, a large number of surgical interventions are relevant.
Study NCT06488833 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Komtü Programme (Komtü)
Description: Mainly, 4 actions will take place:~* Training with reflective practice exercises. This is a 32-hours group training involving 21 sessions that last 60 minutes and 11 hours of inter-sessions work. The contents of the training will be 5 of the 10 total blocks of Komtü training: Block 1: Meeting, observing and listening; Block 2: Neuroscience applied in the educational context; Block 3: High- quality relationships; Block 4: Conflict management; Block 5: Boundary management~* Healing spaces to generate a collective restorative experience, offering tools that facilitate emotional management~* Individual support for teachers to offer them resources, tools, and intervention strategies to help improve educational practice and the emotional and relational well-being of the school community~* Coaching for the school management team to help them establish some objectives together and offer them the necessary resources and tools so that they can achieve them successfully.
Study NCT05199493 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Angiotensin II
Description: Patients with Delta-renin >= 3.7 micro-unit/mL are at high risk for AKI. Patients who have a high delta-renin and a postoperative hypotension requiring vasopressors ad will be randomized. After randomization patients will receive intravenous infusion with the investigational drug.
Study NCT06488833 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Komtü Training and Reflective Practice
Description: This is a 32-hours group training involving 21 sessions that last 60 minutes and 11 hours of inter-sessions work. The contents of the training will be 5 of the 10 total blocks of Komtü training: Block 1: Meeting, observing and listening; Block 2: Neuroscience applied in the educational context; Block 3: High- quality relationships; Block 4: Conflict management; Block 5: Boundary management~No other actions will take place in this group.
Study NCT04414722 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Amoxicillin-Clavulanate 875 Mg-125 Mg Oral Tablet
Description: Amoxicillin-Clavulanate 875 Mg-125 Mg Oral Tablet
Study NCT04414722 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Amoxicillin-Clavulanate 875 Mg-125 Mg Oral Tablet
Description: Amoxicillin-Clavulanate 875 Mg-125 Mg Oral Tablet
Study NCT04414722 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Amoxicillin-Clavulanate 875 Mg-125 Mg Oral Tablet
Description: Amoxicillin-Clavulanate 875 Mg-125 Mg Oral Tablet
Study NCT04414722 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: BB-12
Description: Bifidobacterium animalis subsp. lactis BB-12 (BB-12)-supplemented yogurt
Study NCT04414722 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control Yogurt
Description: Yogurt without Bifidobacterium animalis subsp. lactis BB-12 (BB-12)
Study NCT05199493 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: Patients with Delta-renin >= 3.7 micro-unit/mL are at high risk for AKI. Patients who have a high delta-renin and a postoperative hypotension requiring vasopressors ad will be randomized. After randomization patients will receive intravenous infusion with placebo
Study NCT04644991 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kinesiology taping
Description: Y-type kinesiology tape will be applied to the thoracolumbar fascia in experimental gruoup.
Study NCT04644991 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Six minutes walking test
Description: Participants will be asked to walk as fast as they can for 6 minutes.
Study NCT04644991 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Six minutes walking test
Description: Participants will be asked to walk as fast as they can for 6 minutes.
Study NCT04644991 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Shame Kinesiology Tape
Description: Sham kinesiology tape will be applied to the thoracolumbar fascia in sham gruoup.
Study NCT06061731 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: low-frequency acupoint electrical stimulation
Description: In order to determine the efficacy of low-frequency acupoint electrical stimulation and electroacupuncture to improve thumb to finger action after stroke
Study NCT05685836 — intervention group
Intervention type: DRUG
Intervention: Bevacizumab Zirconium Zr-89
Description: See Arm description.
Study NCT04234997 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Suvorexant 20 mg
Description: Participants will be advised to take the medication at 10PM for 7 days.Participants will be instructed to stop smoking by 10 pm the day before, in order to ensure they meet the breath CO criterion (CO ≤ 4 ppm) indicating overnight abstinence.
Study NCT04234997 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Suvorexant 0mg
Description: Participants will be advised to take the medication at 10PM for 7 days.Participants will be instructed to stop smoking by 10 pm the day before, in order to ensure they meet the breath CO criterion (CO ≤ 4 ppm) indicating overnight abstinence.
Study NCT06564350 — intervention group
Intervention type: DEVICE
Intervention: IMU (Inertial Measurement Unit) sensors
Description: IMU sensors track an object's acceleration and angular velocity over time and do not emit any electromagnetic fields or radiation. They use tiny masses and springs to measure the acceleration, as well as Hall effect materials to measure the magnetic fields. The force sensor changes its electric resistor value based on the force applied to the sensor surface.
Study NCT06637384 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Hyaluronic Acid (HA)
Description: Gengigel Gingival Gel 20ml, Ricerfarma, Milan, Italy
Study NCT06637384 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Corticosteroid Injection
Description: Hydrocortisone Sodium Succinate, Cirin Pharmaceuticals, Pakistan
Study NCT05424523 — intervention group
Intervention type: DRUG
Intervention: Omalizumab
Description: Patients with confirmed diagnosis of allergic asthma, who were prescribed omalizumab
Study NCT05665023 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab + modified FOLFIRINOX
Description: Bevacizumab 5mg/kg D1, oxaliplatin 85 mg/m2 D1 + leucovorin 400mg/m2 D1 + irinotecan 150 mg/m2 D1 + 5-FU 2,400 mg/m2 46h continuous infusion, every other week
Study NCT06639139 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CogFun RG occupational therapy
Description: 21 weekly, online group sessions (4-6 participants in each group), lasting 90 minutes. Sessions are structured, comprising opening, collaborative learning, and summary. Session topics include learning about ADHD as a biological disorder of executive functioning, understanding the impact of ADHD on daily life, discovering strategies for coping with ADHD through exploration of life experiences, and preparing for future self management
Study NCT04118920 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Topical insulin (4 units)
Description: N=6: 100 U/ml; 4 units of insulin per application; 40 microliters per drop
Study NCT04118920 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Topical insulin (20 units)
Description: N=6: 500 U/ml; 20 units of insulin per application; 40 microliters per drop
Study NCT04118920 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Artificial tears
Description: N=3, 40 microliters per drop
Study NCT06638138 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Flexband
Description: Artelon FLEXBAND is a commercially available, polycaprolactone polyurethane urea (PCL/PUUR) multipolymer synthetic knitted mesh that is used for soft tissue reinforcement procedures. The device is biocompatible and degradable and has been used as an augmentation device in over 50,000 Orthopedic tendon and ligament reconstructive procedures. The FLEXBAND kits contain the device and all of the instrumentation needed to insert the device.
Study NCT06640712 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Dental caries was assessed using the DMFT index (Decayed, Missing, and Filled Teeth) according to the World Health Organization's caries diagnostic criteria.
Description: The same psychiatrist administered the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) to all participants. Oral health examinations were performed by a trained dental student and a specialist dentist using a portable dental chair, artificial light, and a dental mirror. Dental caries was assessed using the DMFT index (Decayed, Missing, and Filled Teeth) according to the World Health Organization's caries diagnostic criteria. This index included the number of decayed, missing (due to caries, excluding 3rd molars), and filled teeth in the permanent dentition. The oral health examiners were blinded to each participant's substance use type and sociodemographic information.
Study NCT06640712 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Dental caries was assessed using the DMFT index (Decayed, Missing, and Filled Teeth) according to the World Health Organization's caries diagnostic criteria.
Description: The same psychiatrist administered the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) to all participants. Oral health examinations were performed by a trained dental student and a specialist dentist using a portable dental chair, artificial light, and a dental mirror. Dental caries was assessed using the DMFT index (Decayed, Missing, and Filled Teeth) according to the World Health Organization's caries diagnostic criteria. This index included the number of decayed, missing (due to caries, excluding 3rd molars), and filled teeth in the permanent dentition. The oral health examiners were blinded to each participant's substance use type and sociodemographic information.
Study NCT06640712 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Substance Use Disorder Diagnosis
Description: This intervention involves a psychiatric evaluation conducted by a licensed psychiatrist to diagnose Substance Use Disorder according to the criteria outlined in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). The psychiatrist performs a comprehensive assessment of each participant's substance use history and related behaviors. This diagnosis step is essential for identifying participants with specific substance use disorders, such as Methamphetamine, Cannabis, or Polysubstance Use Disorders, before proceeding with the dental health examination.
Study NCT06563570 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: yoga (online)
Description: 8-week online yoga practices, 2 days a week
Study NCT06637085 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: LLLT
Description: low level laser therapy Probe laser device: (Laserklasse2M, EN60825-1, +A2:2002, W.L= 635-670nm, P\<6mW, German):low level laser therapy It will be used to stimulate vagus nerve .
Study NCT06637085 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: traditional physical therapy
Description: traditional physical therapy include (phase I cardiac rehabilitation, breathing exercises, modified postural drainage, percussion and vibration)
Study NCT06637085 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: traditional physical therapy
Description: traditional physical therapy include (phase I cardiac rehabilitation, breathing exercises, modified postural drainage, percussion and vibration)
Study NCT06637085 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ACU TENSE
Description: Acu-TENS device (Digital TENS, EAF20, JERF20BD0604, add manufacturing country): It will be used to stimulate vagus nerve throug h the acupoint PC6 .
Study NCT06186518 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PİKSEÇ
Description: In designing the PİKSEÇ application, the Turkish validity and reliability version of the 'Difficult Intravenous Access Score' and a literal translation of the miniMAGIC instructions were utilized. The application serves as a guideline for nurses during peripheral intravenous catheter insertion, taking into account parameters such as the patient's age, urgency status, anxiety, and vein characteristics, providing tailored suggestions.~By utilizing the application, nurses can follow evidence-based guidelines more efficiently, ensuring a faster and more practical adherence to the PIVC intervention procedure, ultimately contributing to a safer peripheral intravenous catheter insertion process.
Study NCT06186518 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Routine care
Description: The pediatric unit's PIVC insertion process will be routinely performed in routine care.
Study NCT05280210 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PTC drug screening
Description: PTC is an in vitro tumor model, which serves as a structural and functional unit recapitulating the original tumors in genotype, phenotype, and drug response. PTC will be used in drug screening.
Study NCT04634799 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: TM5614
Description: TM5614 is provided in 30 mg tablets and 6 tablets (180 mg) will be taken in the evening for up to 7 days.
Study NCT06149312 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Advance Care Planning Intervention
Description: Standardized interview based on The letter Project (Stanford Medicine) and Questions Prompt List
Study NCT04634799 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo will be provided and participants will take 6 tablets in the evening for up to 7 days.
Study NCT06558006 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Predimenol tablet
Description: 2 tablets of Predimenol (400 mg Predimenol) will be taken with 220 mL of water (one glass of water).
Study NCT06558006 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Predimenol tablet + Placebo tablet of Predimenol
Description: 1 tablet of Predimenol (200 mg Predimenol) + 1 tablet of placebo will be taken with 220 mL of water (one glass of water).
Study NCT06558006 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo tablet of Predimenol
Description: 2 tablets of placebo tablet of Predimenol will be taken with 220 mL of water (one glass of water).
Study NCT04391309 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: anti-CD14
Description: 4 mg/kg on Day 1, 2 mg/kg on Days 2-4 administered intravenously (IV)
Study NCT05592483 — intervention group
Intervention type: OTHER
Intervention: None (Observational Study)
Description: Not Applicable since observational study
Study NCT06569758 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GenSci098
Description: subcutaneous , 5 dose levels(15mg, 45mg, 90mg, 180mg and 270mg) will be assigned.
Study NCT06569758 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: GenSci098 Placebo
Description: In SAD part only one dose of GenSci098 and GenSci098 Placebo to be given, in MAD part, GenSci098 and GenSci098 will be given on Day 1 and Day 85
Study NCT05829239 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ADI-PEG20
Description: Intramuscular injection weekly for 8 weeks
Study NCT05829239 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Intramuscular injection weekly for 8 weeks
Study NCT06579417 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: RSI MRI
Description: In ART-Pro-1, patients receive standard of care mpMRI, with addition of the RSI sequence, and subsets of the patients' images are read separately by two expert radiologists at the center, one of whom is the standard of care radiologist (Reader 1). Three research reports are generated using: bpMRI only (Reader 1), mpMRI (Reader 1), and bpMRI + RSIrs (Reader 2). The clinical report is submitted by Reader 1. Patients' future prostate cancer management will be recorded and used to evaluate the performance of the MRI techniques being tested.
Study NCT04391309 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo administered intravenously on Days 1-4
Study NCT04391309 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: remdesivir
Description: Remdesivir administered intravenously for 5 days beginning with a 200 mg loading dose on Day 1, followed by 100 mg/day on Days 2-5.
Study NCT04391309 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: remdesivir
Description: Remdesivir administered intravenously for 5 days beginning with a 200 mg loading dose on Day 1, followed by 100 mg/day on Days 2-5.
Study NCT06217029 — intervention group
Intervention type: OTHER
Intervention: physiotherapy and maxillary traction
Description: 1. Mobility exercises~2. Ultrasound or electric stimulation~3. Application of equipment, such as braces, slings and taping~4. Registered massage therapy~5. Trigger point and myofascial release